Effectiveness and risk of ARB and ACEi among different ethnic groups in England: A reference trial (ONTARGET) emulation analysis using UK Clinical Practice Research Datalink Aurum-linked data.

<h4>Background</h4>Guidelines by the National Institute for Health and Care Excellence recommend an angiotensin receptor blocker (ARB) rather than an angiotensin-converting enzyme inhibitor (ACEi) for the treatment of hypertension for people of African and Caribbean descent, due to an in...

Full description

Saved in:
Bibliographic Details
Main Authors: Paris J Baptiste, Angel Y S Wong, Anna Schultze, Catherine M Clase, Clémence Leyrat, Elizabeth Williamson, Emma Powell, Johannes F E Mann, Marianne Cunnington, Koon Teo, Shrikant I Bangdiwala, Peggy Gao, Kevin Wing, Laurie Tomlinson
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-09-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1004465
Tags: Add Tag
No Tags, Be the first to tag this record!